Amgen Inc. (AMG.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 09:08PM CEST
| Previous Close | 259.95 |
| Open | 293.00 |
| Bid | 287.20 x 30000 |
| Ask | 288.55 x 30000 |
| Day's Range | 287.00 - 295.00 |
| 52 Week Range | 199.20 - 304.00 |
| Volume | |
| Avg. Volume | 261 |
| Market Cap | 155.632B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 22.32 |
| EPS (TTM) | 12.86 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | 8.29 (3.19%) |
| Ex-Dividend Date | May 16, 2024 |
| 1y Target Est | N/A |
Yahoo FinanceAmgen's peek at its GLP-1 drug trial results heightens competition in obesity market
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
GuruFocus.comDecoding Amgen Inc (AMGN): A Strategic SWOT Insight
Insightful Analysis of Amgen Inc's Strengths, Weaknesses, Opportunities, and Threats
Barrons.comThese Stocks Moved the Most Today: Apple, Amgen, Expedia, Coinbase, Cloudflare, Fortinet, Live Nation, and More
Apple reports better-than-estimated earnings and expands its buyback program by $110 billion, Amgen ‘very encouraged’ by preliminary data from a trial of a weight-loss drug, and Expedia reduces its sales outlook for the year.
© 2024 Yahoo. All rights reserved.